Free Trial

Carl Zeiss Meditec (ETR:AFX) Stock Price Up 6% - What's Next?

Carl Zeiss Meditec logo with Medical background

Shares of Carl Zeiss Meditec AG (ETR:AFX - Get Free Report) were up 6% on Monday . The company traded as high as €57.10 ($59.48) and last traded at €56.30 ($58.65). Approximately 493,688 shares were traded during trading, an increase of 423% from the average daily volume of 94,405 shares. The stock had previously closed at €53.10 ($55.31).

Carl Zeiss Meditec Price Performance

The firm has a market cap of $5.04 billion, a price-to-earnings ratio of 24.69, a P/E/G ratio of 2.83 and a beta of 0.98. The business's 50-day moving average price is €51.06 and its two-hundred day moving average price is €58.25. The company has a debt-to-equity ratio of 6.74, a current ratio of 3.51 and a quick ratio of 2.47.

About Carl Zeiss Meditec

(Get Free Report)

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Carl Zeiss Meditec Right Now?

Before you consider Carl Zeiss Meditec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Carl Zeiss Meditec wasn't on the list.

While Carl Zeiss Meditec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash
NVIDIA Stock Under Pressure: DeepSeek and the AI Tech War
Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines